LYGENESIS
LyGenesis is an organ regeneration company enabling a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs. Their initial target organ for clinical development is liver regeneration, with a focus on helping patients with end stage liver disease (ESLD).
LYGENESIS
Social Links:
Industry:
Biotechnology Clinical Trials Medical
Founded:
2017-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.lygenesis.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
18 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Euro Microsoft Exchange Online Amazon Office 365 Mail Typekit
Similar Organizations
Anelixis Therapeutics
Anelixis Therapeutics is a biotechnology company that facilitates pre-clinical drug development.
AOBiome
AOBiome is a life sciences company that focuses on transforming human health.
Current Advisors List
Current Employees Featured
Founder
Investors List
Longevity Vision Fund
Longevity Vision Fund investment in Convertible Note - LyGenesis
Juvenescence
Juvenescence investment in Convertible Note - LyGenesis
Longevity Vision Fund
Longevity Vision Fund investment in Debt Financing - LyGenesis
Juvenescence
Juvenescence investment in Debt Financing - LyGenesis
Juvenescence
Juvenescence investment in Series A - LyGenesis
Official Site Inspections
http://www.lygenesis.com Semrush global rank: 5.74 M Semrush visits lastest month: 1.46 K
- Host name: acd89244c803f7181.awsglobalaccelerator.com
- IP address: 75.2.60.5
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "LyGenesis"
Lygenesis
LyGenesis, Inc. is a clinical-stage cell therapy company that transforms a patient’s lymph nodes into bioreactors capable of growing functioning ectopic organs.See details»
About Us - Lygenesis
LyGenesis, Inc. is a clinical-stage cell therapy company that transforms a patient's lymph nodes into bioreactors capable of growing functioning ectopic organs. Instead of one donor organ …See details»
Our Science - Lygenesis
LyGenesis uses the lymph node's evolutionary function - to serve as an efficient and rapid bioreactor for T-cell to help fight infection - to help vascularize our allogenic cell therapies, a key barrier to the successful clinical application of …See details»
LyGenesis - Crunchbase Company Profile & Funding
LyGenesis is an organ regeneration company enabling a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs. Their initial target organ for clinical …See details»
This company is about to grow new organs in a person …
Aug 25, 2022 · The company behind the treatment, LyGenesis, hopes to save people with devastating liver diseases who are not eligible for transplants. Their approach is to inject liver cells from a donor into...See details»
This Bag of Cells Could Grow New Livers Inside of People
Apr 2, 2024 · Now, biotech company LyGenesis is trying to turn the concept into reality. Today, LyGenesis announced that an initial volunteer has received an injection of donor cells to turn one of their...See details»
Innovation in Liver Failure Treatment: Growing a Mini Liver in …
Apr 5, 2024 · Revolutionary treatment: LyGenesis pioneers mini-liver growth in lymph nodes, offering hope for liver failure patients. Discover the groundbreaking procedure now.See details»
LyGenesis Announces First Patient Dosed in its Phase …
Apr 2, 2024 · LyGenesis, a clinical-stage biotechnology company developing cell therapies for large unmet medical needs, announced today that the first patient has been dosed in their Phase 2a clinical trial...See details»
‘Mini liver’ will grow in person’s own lymph node in …
Apr 2, 2024 · Biotechnology firm LyGenesis has injected donor cells into a person with liver failure for the first time. Researchers injected a mouse’s lymph node with liver cells (green), converting the organ...See details»
LyGenesis Aims to Transplant Liver Tissue into Lymph Nodes
Feb 27, 2018 · LyGenesis, Inc. is an organ regeneration company enabling a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs. Our initial target organ …See details»
LyGenesis Announces First Patient Dosed in its Phase …
Apr 2, 2024 · LyGenesis is a clinical-stage biotechnology company developing a novel cell therapy platform leveraging patients' lymph nodes as bioreactors to grow functioning ectopic organs.See details»
LyGenesis Raises $19M in Series A-2 Funding Led by Prime Movers …
PITTSBURGH, Oct. 24, 2023 /PRNewswire/ -- LyGenesis, a clinical-stage biotechnology company developing cell therapies for patients with end stage liver disease, type 1 diabetes, …See details»
Allogeneic cell therapies for end-stage liver disease, type
Apr 11, 2023 · LyGenesis is a clinical-stage biotechnology company developing a novel cell therapy platform leveraging patients' lymph nodes as bioreactors to grow functioning ectopic …See details»
LyGenesis and Imagine Pharma Announce Joint Research …
Apr 11, 2023 · LyGenesis is a clinical-stage biotechnology company developing a novel cell therapy platform leveraging patients' lymph nodes as bioreactors to grow functioning ectopic …See details»
Eric Lagasse and LyGenesis begin Phase II Clinical Trial
Apr 18, 2024 · PLRC researcher Dr. Eric Lagasse, PhD, PharmD, and his company LyGenesis have launched a Phase II clinical trial in which healthy donor hepatocytes are transplanted into …See details»
LyGenesis and Imagine Pharma Announce Joint Research …
Apr 11, 2023 · LyGenesis is a clinical-stage biotechnology company developing a novel cell therapy platform leveraging patients’ lymph nodes as bioreactors to grow functioning ectopic …See details»
LyGenesis Announces Four Peer-Reviewed Publications on its …
LyGenesis's lead allogeneic cell therapy program is focused on liver regeneration for patients with end stage liver disease. Its pipeline with positive preclinical data includes thymus, pancreas, …See details»
Experimental Therapy Could Grow You Brand New Livers - Gizmodo
Apr 3, 2024 · LyGenesis is hoping to win approval for LYG-LIV-001 as a treatment for end-stage liver disease, or ESLD, a severe state of chronic organ damage. Though someone can live …See details»
LyGenesis Announces a New Peer-Reviewed Publication …
Jan 20, 2022 · LyGenesis's technology is built on a broad foundation of small and large animal preclinical studies showing that lymph nodes can serve as sites for organogenesis – the …See details»
LyGenesis Receives FDA Clearance to Begin Phase 2a Trial of its …
PITTSBURGH, Dec. 30, 2020 /PRNewswire/ -- LyGenesis, Inc., a biotechnology company developing cell therapies that enable organ regeneration, announced today that the U.S Food …See details»